{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:46:45Z","timestamp":1791499605243,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui Provincial Health Commission Provincial Financial Support for Youth Programs","award":["AHWJ2023A30159"],"award-info":[{"award-number":["AHWJ2023A30159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02679-w","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T16:04:49Z","timestamp":1747670689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The causal association between psoriasis and 32 types of cancer: a mendelian randomization study"],"prefix":"10.1007","volume":"16","author":[{"given":"Guangyao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"2679_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/BOR.0000000000001064","volume":"37","author":"F Saeed","year":"2025","unstructured":"Saeed F, Adamopoulos IE. Pathogenesis of psoriatic arthritis: new insights from a bone marrow perspective. Curr Opin Rheumatol. 2025;37:136\u201341.","journal-title":"Curr Opin Rheumatol"},{"key":"2679_CR2","doi-asserted-by":"publisher","first-page":"103709","DOI":"10.1016\/j.autrev.2024.103709","volume":"24","author":"D Gamus","year":"2025","unstructured":"Gamus D, Shoenfeld Y. Acupuncture therapy in autoimmune diseases: a narrative review. Autoimmun Rev. 2025;24:103709.","journal-title":"Autoimmun Rev"},{"key":"2679_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/ijms26020749","volume":"26","author":"OA Orzan","year":"2025","unstructured":"Orzan OA, Tutunaru CV, Iano\u0219i SL. Understanding the intricate pathophysiology of psoriasis and related skin disorders. Int J Mol Sci. 2025;26:749.","journal-title":"Int J Mol Sci"},{"key":"2679_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.it.2025.01.002","volume":"46","author":"PE Saw","year":"2025","unstructured":"Saw PE, Song E. The \u2018inflammazone\u2019 in chronic inflammatory diseases: psoriasis and sarcoidosis. Trends Immunol. 2025;46:121\u201337.","journal-title":"Trends Immunol"},{"key":"2679_CR5","doi-asserted-by":"publisher","first-page":"103758","DOI":"10.1016\/j.autrev.2025.103758","volume":"24","author":"DK Jha","year":"2025","unstructured":"Jha DK, Kakadiya R, Sharma A, Naidu S, De D, Sharma V. Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: a comprehensive review. Autoimmun Rev. 2025;24:103758.","journal-title":"Autoimmun Rev"},{"key":"2679_CR6","doi-asserted-by":"publisher","first-page":"113952","DOI":"10.1016\/j.intimp.2024.113952","volume":"147","author":"G Li","year":"2025","unstructured":"Li G, Li S, Jiang Y, Chen T, An Z. Unleashing the power of immune checkpoints: a new strategy for enhancing Treg cells depletion to boost antitumor immunity. Int Immunopharmacol. 2025;147:113952.","journal-title":"Int Immunopharmacol"},{"key":"2679_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41573-024-01053-9","volume":"23","author":"M Croft","year":"2024","unstructured":"Croft M, Salek-Ardakani S, Ware CF. Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer. Nat Rev Drug Discov. 2024;23:939\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"2679_CR8","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.3390\/cancers16244224","volume":"16","author":"L-A Mateescu","year":"2024","unstructured":"Mateescu L-A, Savu A-P, Mutu C-C, Vaida C-D, \u0218erban E-D, Bucur \u0218, et al. The intersection of psoriasis and neoplasia: risk factors, therapeutic approaches, and management strategies. Cancers. 2024;16:4224.","journal-title":"Cancers"},{"key":"2679_CR9","doi-asserted-by":"crossref","unstructured":"Meng Y, Zhou Q, Dian Y, Zeng F, Deng G, Chen X. Ferroptosis: a targetable vulnerability for melanoma treatment. J Invest Dermatol. 2025:S0022202X24030240.","DOI":"10.1016\/j.jid.2024.11.007"},{"key":"2679_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.7150\/jca.37015","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang X, Liu Q, Wu L, Nie Z, Mei Z. Risk of non-melanoma skin cancer in patients with psoriasis: an updated evidence from systematic review with meta-analysis. J Cancer. 2020;11:1047\u201355.","journal-title":"J Cancer"},{"key":"2679_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaad.2021.07.050","volume":"86","author":"F Bellinato","year":"2022","unstructured":"Bellinato F, Gisondi P, Girolomoni G. Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: a systematic review with meta-analysis. J Am Acad Dermatol. 2022;86:86\u201396.","journal-title":"J Am Acad Dermatol"},{"key":"2679_CR12","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925.","journal-title":"JAMA"},{"key":"2679_CR13","first-page":"766","volume":"110","author":"X Zou","year":"2024","unstructured":"Zou X, Wang L, Wang S, Zhang Y, Ma J, Chen L, et al. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study. Int J Surg. 2024;110:766\u201376.","journal-title":"Int J Surg"},{"key":"2679_CR14","doi-asserted-by":"publisher","first-page":"105168","DOI":"10.1016\/j.ebiom.2024.105168","volume":"105","author":"TA Desai","year":"2024","unstructured":"Desai TA, Hedman \u00c5K, Dimitriou M, Koprulu M, Figiel S, Yin W, et al. Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics. EBioMedicine. 2024;105:105168.","journal-title":"EBioMedicine"},{"key":"2679_CR15","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awad070","volume":"146","author":"J Lin","year":"2023","unstructured":"Lin J, Zhou J, Xu Y. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Brain. 2023;146:3364\u201372.","journal-title":"Brain"},{"key":"2679_CR16","doi-asserted-by":"publisher","first-page":"15382","DOI":"10.1038\/ncomms15382","volume":"8","author":"LC Tsoi","year":"2017","unstructured":"Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382.","journal-title":"Nat Commun"},{"key":"2679_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jaad.2022.10.019","volume":"88","author":"CV Chalitsios","year":"2023","unstructured":"Chalitsios CV, Tsilidis KK, Tzoulaki I. Psoriasis and COVID-19: a bidirectional Mendelian randomization study. J Am Acad Dermatol. 2023;88:893\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"2679_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/ng.3685","volume":"48","author":"C Lesseur","year":"2016","unstructured":"Lesseur C, Diergaarde B, Olshan AF, W\u00fcnsch-Filho V, Ness AR, Liu G, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48:1544\u201350.","journal-title":"Nat Genet"},{"key":"2679_CR19","doi-asserted-by":"crossref","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, EPIC-InterAct Consortium. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30:543\u201352.","DOI":"10.1007\/s10654-015-0011-z"},{"key":"2679_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"2679_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985\u201398.","journal-title":"Int J Epidemiol"},{"key":"2679_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"2679_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365.","journal-title":"Genet Epidemiol"},{"key":"2679_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"2679_CR25","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey SG. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLOS Genet. 2017;13:e1007081.","journal-title":"PLOS Genet"},{"key":"2679_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2679_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/nu17020287","volume":"17","author":"N Zalaquett","year":"2025","unstructured":"Zalaquett N, Lidoriki I, Lampou M, Saab J, Hadkhale K, Christophi C, et al. Adherence to the Mediterranean diet and the risk of head and neck cancer: a systematic review and meta-analysis of case-control studies. Nutrients. 2025;17:287.","journal-title":"Nutrients"},{"key":"2679_CR28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","volume":"155","author":"AM Trafford","year":"2019","unstructured":"Trafford AM, Parisi R, Kontopantelis E, Griffiths CEM, Ashcroft DM. Association of psoriasis with the risk of developing or dying of cancer: a systematic review and meta-analysis. JAMA Dermatol. 2019;155:1390.","journal-title":"JAMA Dermatol"},{"key":"2679_CR29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1523-1747.2000.00898.x","volume":"114","author":"A Hannuksela-Svahn","year":"2000","unstructured":"Hannuksela-Svahn A, Pukkala E, L\u00e4\u00e4r\u00e4 E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of finnish patients. J Invest Dermatol. 2000;114:587\u201390.","journal-title":"J Invest Dermatol"},{"key":"2679_CR30","doi-asserted-by":"crossref","unstructured":"Stern RS, PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66:553\u201362.","DOI":"10.1016\/j.jaad.2011.04.004"},{"key":"2679_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1017\/S0954422423000185","volume":"37","author":"P Hawkins","year":"2024","unstructured":"Hawkins P, Earl K, Tektonidis TG, Fallaize R. The role of diet in the management of psoriasis: a scoping review. Nutr Res Rev. 2024;37:296\u2013330.","journal-title":"Nutr Res Rev"},{"key":"2679_CR32","doi-asserted-by":"crossref","unstructured":"Dhabale A, Nagpure S. Types of psoriasis and their effects on the immune system. Cureus. 2022.","DOI":"10.7759\/cureus.29536"},{"key":"2679_CR33","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3390\/ijms21155405","volume":"21","author":"N Kanda","year":"2020","unstructured":"Kanda N, Hoashi T, Saeki H. Nutrition and psoriasis. Int J Mol Sci. 2020;21:5405.","journal-title":"Int J Mol Sci"},{"key":"2679_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5603\/FHC.2014.0018","volume":"52","author":"T Tyszkiewicz","year":"2014","unstructured":"Tyszkiewicz T, Jarzab M, Szymczyk C, Kowal M, Krajewska J, Jaworska M, et al. Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa. Folia Histochem Cytobiol. 2014;52:79\u201389.","journal-title":"Folia Histochem Cytobiol"},{"key":"2679_CR35","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.7150\/ijms.5986","volume":"10","author":"C Wang","year":"2013","unstructured":"Wang C, Zhang Z, Li L, Zhang J, Wang J, Fan J, et al. S100A11 is a migration-related protein in laryngeal squamous cell carcinoma. Int J Med Sci. 2013;10:1552\u20139.","journal-title":"Int J Med Sci"},{"key":"2679_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","volume":"123","author":"RL Eckert","year":"2004","unstructured":"Eckert RL, Broome A-M, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J Invest Dermatol. 2004;123:23\u201333.","journal-title":"J Invest Dermatol"},{"key":"2679_CR37","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1038\/sj.onc.1211015","volume":"27","author":"G Zhou","year":"2008","unstructured":"Zhou G, Xie T-X, Zhao M, Jasser SA, Younes MN, Sano D, et al. Reciprocal negative regulation between S100A7\/psoriasin and \u03b2-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene. 2008;27:3527\u201338.","journal-title":"Oncogene"},{"key":"2679_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759\u201371.","journal-title":"Nat Rev Cancer"},{"key":"2679_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jid.2020.05.115","volume":"141","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Baumer Y, Dey AK, Grattan R, Ng Q, Teague HL, et al. Characterization of PCSK9 in the blood and skin of psoriasis. J Invest Dermatol. 2021;141:308\u201315.","journal-title":"J Invest Dermatol"},{"key":"2679_CR40","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C, He Z, Wang R, Xu Y, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13:1774\u2013808.","journal-title":"Theranostics"},{"key":"2679_CR41","doi-asserted-by":"publisher","first-page":"112561","DOI":"10.1016\/j.intimp.2024.112561","volume":"138","author":"A Ebrahimi","year":"2024","unstructured":"Ebrahimi A, Mehrabi M, Miraghaee SS, Mohammadi P, Fatehi Kafash F, Delfani M, et al. Flavonoid compounds and their synergistic effects: promising approaches for the prevention and treatment of psoriasis with emphasis on keratinocytes\u2014a systematic and mechanistic review. Int Immunopharmacol. 2024;138:112561.","journal-title":"Int Immunopharmacol"},{"key":"2679_CR42","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.jaut.2021.102614","volume":"118","author":"AK Srivastava","year":"2021","unstructured":"Srivastava AK, Chand Yadav T, Khera HK, Mishra P, Raghuwanshi N, et al. Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities. J Autoimmun. 2021;118:102614.","journal-title":"J Autoimmun"},{"key":"2679_CR43","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jid.2016.04.032","volume":"136","author":"J Kim","year":"2016","unstructured":"Kim J, Bissonnette R, Lee J, Correa Da Rosa J, Su\u00e1rez-Fari\u00f1as M, Lowes MA, et al. The spectrum of mild to severe psoriasis vulgaris is defined by a common activation of IL-17 pathway genes, but with key differences in immune regulatory genes. J Invest Dermatol. 2016;136:2173\u201382.","journal-title":"J Invest Dermatol"},{"key":"2679_CR44","doi-asserted-by":"crossref","unstructured":"Leane CM, Sutton CE, Moran B, Mills KHG. PD\u20101 regulation of pathogenic IL\u201017\u2010secreting \u03b3\u03b4 T cells in experimental autoimmune encephalomyelitis. Eur J Immunol. 2024:2451212.","DOI":"10.1002\/eji.202451212"},{"key":"2679_CR45","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/cancers16061226","volume":"16","author":"M Absmaier-Kijak","year":"2024","unstructured":"Absmaier-Kijak M, Iuliano C, Kaesler S, Biedermann T, Posch C, Brockow K. T-cell subtypes and immune signatures in cutaneous immune-related adverse events in melanoma patients under immune checkpoint inhibitor therapy. Cancers. 2024;16:1226.","journal-title":"Cancers"},{"key":"2679_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/life13020419","volume":"13","author":"A Olveira","year":"2023","unstructured":"Olveira A, Augustin S, Benlloch S, Ampuero J, Su\u00e1rez-P\u00e9rez JA, Armesto S, et al. The essential role of IL-17 as the Pathogenetic link between psoriasis and metabolic-associated fatty liver disease. Life. 2023;13:419.","journal-title":"Life"},{"key":"2679_CR47","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jaad.2024.05.072","volume":"91","author":"HY Gantz","year":"2024","unstructured":"Gantz HY, Greenzaid JD, Feldman SR. Atopic dermatitis may not confer clinically meaningful risk of inflammatory bowel disease or renal malignancy. J Am Acad Dermatol. 2024;91:586\u20138.","journal-title":"J Am Acad Dermatol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02679-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02679-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02679-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T17:03:17Z","timestamp":1747674197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02679-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2679"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02679-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our analyses used published studies in public databases or publicly available data. Raw data were not collected for the datasets used, so ethics committee approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the content and submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"819"}}